Clinical prognostic factors in multiple sclerosis: a natural history review. - Test2 - elhamkhani - TriplyDB

Clinical prognostic factors in multiple sclerosis: a natural history review.

Clinical prognostic factors in multiple sclerosis: a natural history review.

http://www.wikidata.org/entity/Q37642594

about

Multiple Sclerosis: Where Will We Be in 2020?Information provision for people with multiple sclerosis Application of the 2010 revised criteria for the diagnosis of multiple sclerosis to patients with clinically isolated syndromes Development of oral immunomodulatory agents in the management of multiple sclerosis Heterogeneity of sickness absence and disability pension trajectories among individuals with MS Comparison of disease activity in SPMS and PPMS in the context of multicenter clinical trials.Evidence for early, non-lesional cerebellar damage in patients with multiple sclerosis: DTI measures correlate with disability, atrophy, and disease duration.Gut microbiome and the risk factors in central nervous system autoimmunity.Prognostic risk estimates of patients with multiple sclerosis and their physicians: comparison to an online analytical risk counseling tool Defective structural RNA processing in relapsing-remitting multiple sclerosis Obesity and Multiple Sclerosis: A Mendelian Randomization Study.How Do People with Multiple Sclerosis Experience Prognostic Uncertainty and Prognosis Communication? A Qualitative Study.Patient Satisfaction with the New Interferon Beta-1b Autoinjector (BETACONNECT™).Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis.Disability in multiple sclerosis: a reference for patients and clinicians.Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period.Progressive Dwindling in Multiple Sclerosis: An Opportunity to Improve Care Mortality in patients with multiple sclerosis Short-term MRI measurements as predictors of EDSS progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life setting Using EAE to better understand principles of immune function and autoimmune pathology Hematopoietic SCT for the treatment of multiple sclerosis.What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 2: chronic progressive and relapsing disease.Novel therapeutic options for multiple sclerosis.Balancing Early Aggression Against Risk of Progression in Multiple Sclerosis.Impaired health-related quality of life predicts progression of disability in multiple sclerosis.A mechanistic, stochastic model helps understand multiple sclerosis course and pathogenesis.Anemoside A3 ameliorates experimental autoimmune encephalomyelitis by modulating T helper 17 cell response.Effect of aqueous extract of Achillea millefolium on the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.A web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis.Use of natalizumab in patients with active relapsing-remitting multiple sclerosis in Kuwait.Progression rates and sample size estimates for PPMS based on the CLIMB study population.Characterising aggressive multiple sclerosis.Mortality and cause of death in multiple sclerosis: findings from a prospective population-based cohort in Bizkaia, Basque Country, Spain.Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study.Multiple Sclerosis: Basic and Clinical.Fatigue after a first attack of suspected multiple sclerosis.Multiple sclerosis and rehabilitation: an overview of the different rehabilitation settings.Brain atrophy and lesion load predict long term disability in multiple sclerosis.Evidence-based patient information programme in early multiple sclerosis: a randomised controlled trial.

P2860

Q22252863-B6D012BB-7B26-46F5-860C-EA3944652158 Q24195040-3608D9FC-8C04-4AA1-945B-4EB757F59ECF Q28295788-AFD155E5-90DB-401C-88A0-398A474DCB1C Q28388704-9A1A3BE5-2916-4A92-9ECE-70B1D32C9FB4 Q33693039-8C750CD2-8A49-4B0C-AD3E-225280FBB757 Q34437540-89843AEA-E9CC-47EE-8EA4-0302E70895C8 Q34474046-85BEB331-48D0-4CF0-BC8E-1A6480041AFE Q34624054-18696B7C-4C28-4EA6-89EB-DD8F287702AE Q34729752-AA283C43-48AC-4126-8CC9-31E68F3B28CB Q35491908-AB6D050E-0B18-4B62-BB6F-B3F324C724CB Q36063065-A161C24A-24A7-4080-9B21-A88541A252CF Q36081882-28FBD4E9-4EBB-4FC5-A918-734CA7627802 Q36389706-8CF307BC-8A16-46E2-B36B-CD40DC12C774 Q36496516-2B6B9BED-7B83-45A8-AA13-7E418C572E53 Q36538190-94F8533C-CF83-4CB4-97FE-46FCB8814EAE Q36841485-BB221E20-4EE8-4B5E-9EFF-C5917A005BED Q37071396-A4DA2756-5FD0-42CA-A557-9CDB9F5F6D3D Q37115005-0FDAD7BF-23F9-4A83-AB1C-1EAE0EB55533 Q37163309-5AF1B44D-4512-4D21-BE11-4F6C46D17AE1 Q37282063-0DA5D97B-E69B-48B8-943B-4C3AA9751F7B Q37657501-15D02608-4D75-41A8-ABD4-F61ED11BD79A Q37778984-412FE3E1-6D6D-496E-B360-45AA3B543336 Q38088747-B2469A6A-50E6-4AC6-882A-B301EDBFE3A1 Q38170129-1E05E65E-7218-47C9-B06A-E4E23B8E83C5 Q38649412-4FA07A05-1A75-40EB-B33B-A91970BBAB67 Q39595351-D17E3ACF-A0C3-4E82-A54B-6FD39AC4B7C3 Q40507937-D8C51F98-A0DA-4C82-9809-26E3FF2DC2C7 Q41185707-A74CBC11-D390-4660-9CC5-10DB357899C8 Q41229256-DD73B920-FAEE-4D10-A641-868EEBB172D0 Q41433436-E57F4161-B80E-4F49-AABE-D1E818CCF0BF Q42288520-34A8EB72-C0C1-4B38-87A9-2257929A7E19 Q44248436-0E4C9B2A-6798-46FE-854D-658353E1A3A9 Q45145307-864469C7-335B-4C72-9F09-C92EEF44E974 Q46425910-10C4D8BD-D2E1-48FC-9061-1C4A40B39154 Q46760321-632F187F-C141-4638-94DB-06FACDCE0DF3 Q47677846-045731F8-5548-4F60-B859-E5ED74A7024F Q47879554-FDD04B21-B736-4C1E-B886-FDA671F78A1F Q47979672-AEDA3BC4-400F-4254-8F22-28E55F90F217 Q48112804-E282723F-877E-4BB5-A8FE-589BA614CEC8 Q48416924-7AC50DC1-49FA-4DE3-9169-568A53CB8AD6

P2860

Clinical prognostic factors in multiple sclerosis: a natural history review.

http://www.wikidata.org/entity/Q37642594

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clinical prognostic factors in multiple sclerosis: a natural history review.

@en

Clinical prognostic factors in multiple sclerosis: a natural history review.

@nl

type

label

Clinical prognostic factors in multiple sclerosis: a natural history review.

@en

Clinical prognostic factors in multiple sclerosis: a natural history review.

@nl

prefLabel

Clinical prognostic factors in multiple sclerosis: a natural history review.

@en

Clinical prognostic factors in multiple sclerosis: a natural history review.

@nl

P1433

Q37642594-3A6810E3-F02E-4816-9D61-4AEA418653CC

P1476

Q37642594-FACC1A31-8C11-4E36-AA7A-AA43284E1635

P2093

Q37642594-041E4575-0983-41A5-8FEB-65F45F338521

Q37642594-087D45FA-5967-4756-885E-80BB6E7F79F9

Q37642594-72D2BFC4-C203-440D-B9B3-317961304597

Q37642594-DC09EF40-4879-4FEF-817E-BF0860116021

P2860

Q37642594-15ED87E5-8BC5-47B3-B17F-7F9FBC6E6F3E

Q37642594-28211FEE-3EF9-4740-BAAD-CB56D7C135A0

Q37642594-2BCD31C5-DDC9-49B3-ACDD-7CECD77F7269

Q37642594-4EA2C231-F329-47CD-8AA9-F2F4D97F1F16

Q37642594-57AB890D-E12D-4CD8-B409-3947642C1D78

Q37642594-647EACC2-2324-4FF5-AB87-6A338A696626

Q37642594-692BC5B4-0AB7-432D-B4AF-1F564F7BE16C

Q37642594-84A3881C-0BC8-41A1-90E8-A2F7FA08012A

Q37642594-87607608-7746-4449-AC3D-FCF45829C166

Q37642594-92435B8E-2C48-4733-ABD2-5484ECE466FA

P2888

Q37642594-83A9D91C-C30D-4104-94AA-7BC370B84A84

P304

Q37642594-653E64DF-9257-4240-AA23-A4C9D4AAC6D1

P31

Q37642594-ED978488-8CD2-4418-8F7F-96CB4B1A21C1

P356

Q37642594-7C3CFC28-CFB3-408A-9060-B3766D81CDA8

P407

Q37642594-D2825ABC-B8DC-46CC-AB08-68CE95389FB5

P433

Q37642594-72502D7A-3B1C-42A8-AE68-442F7C3A34E7

P478

Q37642594-DEB732F1-94C2-4793-BE41-49AB6BA3E499

P577

Q37642594-556B0667-C551-45AB-AAF8-E8619CF1B91B

P698

Q37642594-F5BFE09B-FE4C-4B22-988C-C498474CBF6E

P921

Q37642594-6DDB4DFD-1655-433B-A09C-B235BF795959

P356

NRNEUROL.2009.178

P1433

Nature Reviews Neurology

P1476

Clinical prognostic factors in multiple sclerosis: a natural history review.

@en

P2093

Alexandra Degenhardt

http://www.w3.org/2001/XMLSchema#string

Antonio Scalfari

http://www.w3.org/2001/XMLSchema#string

George C Ebers

http://www.w3.org/2001/XMLSchema#string

Sreeram V Ramagopalan

http://www.w3.org/2001/XMLSchema#string

P2860

Defining the clinical course of multiple sclerosis: Results of an international survey

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension

Cause of death in patients attending multiple sclerosis clinics

Disability profile of MS did not change over 10 years in a population-based prevalence cohort.

Epidemiology of multiple sclerosis in US veterans: VII. Risk factors for MS.

Survival of patients with multiple sclerosis in Denmark: a nationwide, long-term epidemiologic survey.

Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000.

Studies on the natural history of multiple sclerosis. 3. Epidemiologic analysis of the army experience in World War II.

Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution.

P2888

nrneurol.2009.178

P304

672-682

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRNEUROL.2009.178

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19953117

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis